Testosterone use and shorter electrocardiographic QT interval duration in men living with and without HIV

P. G. Hiremath, F. Bhondoekhan, S. A. Haberlen, H. Ashikaga, F. J. Palella, G. D’Souza, M. J. Budoff, L. A. Kingsley, A. S. Dobs, W. S. Post, E. Z. Soliman, T. T. Brown, K. C. Wu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Objectives: Testosterone usage (T-use) may alter risk factors for sudden cardiac death in men living with HIV (MLWH). Electrocardiographic QT interval prolongation, which could potentiate ventricular arrhythmias, has previously been associated with HIV infection and, separately, with low testosterone levels. We investigated whether T-use shortens the QT interval duration in MLWH and HIV-uninfected men. Methods: We utilized data from the Multicenter AIDS Cohort Study, a prospective, longitudinal study of HIV infection among men who have sex with men. Multivariable linear regression analyses were used to evaluate associations between T-use and corrected QT interval (QTc) duration. Results: Testosterone usage was more common in MLWH compared with HIV-uninfected men (19% vs. 9%). In a multivariable regression analysis, T-use was associated with a 5.7 ms shorter QT interval [95% confidence interval (CI): −9.5 to −1.9; P = 0.003). Furthermore, stronger associations were observed for prolonged duration of T-use and recent timing of T-use. Conclusions: This study is the first known analysis of T-use and QTc interval in MLWH. Overall, our data demonstrate that recent T-use is associated with a shorter QTc interval. Increased T-use duration above a threshold of ≥ 50% of visits in the preceding 5 years was associated with a shorter QTc interval while lesser T-use duration was not.

Original languageEnglish (US)
Pages (from-to)418-421
Number of pages4
JournalHIV Medicine
Volume22
Issue number5
DOIs
StatePublished - May 2021

Funding

Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS), now the MACS/WIHS Combined Cohort Study (MWCCS), which is supported by the National Institutes of Health (full acknowledgement can be found here: https://statepi.jhsph.edu/mwccs/acknowledgements/ ). TTB is supported in part by NIH/NIAID K24 AI120834. Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS), now the MACS/WIHS Combined Cohort Study (MWCCS), which is supported by the National Institutes of Health (full acknowledgement can be found here: https://statepi.jhsph.edu/mwccs/acknowledgements/). TTB is supported in part by NIH/NIAID K24 AI120834. Conflict of interest: There are no conflicts of interest. All authors participated in the work and reviewed and agree with the content of the article.

Keywords

  • HIV
  • QT interval
  • testosterone usage

ASJC Scopus subject areas

  • Health Policy
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Testosterone use and shorter electrocardiographic QT interval duration in men living with and without HIV'. Together they form a unique fingerprint.

Cite this